{"id":"doi:10.1111/dom.14863","kind":"review","title":"Semaglutide for the treatment of overweight and obesity: A review","authors":["Natasha Chidekel Bergmann","Melanie Jane Davies","Ildiko Lingvay","Filip Krag Knop"],"author_count":4,"year":2022,"published":"2022-10-18","venue":"Diabetes Obesity and Metabolism","cited_by":266,"doi":"10.1111/dom.14863","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1111/dom.14863","archive_url":"https://space-kitty.com/papers/doi:10.1111/dom.14863","updated":null,"pmid":"36254579","pmcid":null,"openalex_id":"W4306681944","pdf_url":null,"abstract":null,"abstract_license":null,"license":"cc-by-nc","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}